tradingkey.logo

Zimmer Biomet Holdings Inc

ZBH

102.332USD

-0.718-0.70%
交易中 美東報價延遲15分鐘
20.37B總市值
22.54本益比TTM

Zimmer Biomet Holdings Inc

102.332

-0.718-0.70%
關於 Zimmer Biomet Holdings Inc 公司
Zimmer Biomet Holdings, Inc. 是一家全球醫療技術公司。其部門包括美洲、歐洲、中東和非洲 (EMEA) 以及亞太地區。該公司設計、製造和銷售骨科重建產品;生物製劑、運動醫學、四肢和創傷 (SET) 產品;顱頜面和胸部 (CMFT) 產品;外科產品;以及一套利用數據、數據分析和人工智能的集成數字和機器人技術。其產品和解決方案有助於治療患有骨骼、關節或支持軟組織疾病或損傷的患者。其膝關節品牌包括 Persona Knee、NexGen 膝關節植入物、Vanguard Knee 和 Oxford Partial Knee。其髖關節品牌包括 Taperloc 髖關節系統、Avenir 完整髖關節系統、Arcos 模塊化髖關節系統和 G7 髖臼系統。其 SET 產品類別包括運動醫學、生物製劑、足部和踝關節等。
公司簡介
公司代碼ZBH
公司名稱Zimmer Biomet Holdings Inc
上市日期Jul 25, 2001
成立日期2001
CEOMr. Ivan Tornos
員工數量17000
證券類型Ordinary Share
年結日Jul 25
公司地址345 E Main St
城市WARSAW
上市交易所NYSE Consolidated
國家United States of America
郵編46580-2746
電話15742676131
網址https://www.zimmerbiomet.com/en
公司代碼ZBH
上市日期Jul 25, 2001
成立日期2001
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. Chad F. Phipps
Mr. Chad F. Phipps
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
59.37K
+2.19%
Mr. Ivan Tornos
Mr. Ivan Tornos
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
51.75K
+9.73%
Mr. Suketu P. Upadhyay
Mr. Suketu P. Upadhyay
Chief Financial Officer, Executive Vice President - Finance, Operations and Supply Chain
Chief Financial Officer, Executive Vice President - Finance, Operations and Supply Chain
48.85K
+5.46%
Mr. Sang Yi
Mr. Sang Yi
Group President, Asia Pacific
Group President, Asia Pacific
21.42K
+12.41%
Mr. Mark Bezjak
Mr. Mark Bezjak
President - Americas
President - Americas
13.13K
+8.09%
Ms. Lori Winkler
Ms. Lori Winkler
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
9.79K
-3.72%
Ms. Betsy J. Bernard
Ms. Betsy J. Bernard
Independent Director
Independent Director
5.27K
--
Mr. Syed A. Jafry
Mr. Syed A. Jafry
Independent Director
Independent Director
4.06K
--
Mr. Robert A. Hagemann
Mr. Robert A. Hagemann
Independent Director
Independent Director
4.00K
--
Mr. Christopher B. (Chris) Begley
Mr. Christopher B. (Chris) Begley
Independent Chairman of the Board
Independent Chairman of the Board
3.54K
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Chad F. Phipps
Mr. Chad F. Phipps
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
59.37K
+2.19%
Mr. Ivan Tornos
Mr. Ivan Tornos
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
51.75K
+9.73%
Mr. Suketu P. Upadhyay
Mr. Suketu P. Upadhyay
Chief Financial Officer, Executive Vice President - Finance, Operations and Supply Chain
Chief Financial Officer, Executive Vice President - Finance, Operations and Supply Chain
48.85K
+5.46%
Mr. Sang Yi
Mr. Sang Yi
Group President, Asia Pacific
Group President, Asia Pacific
21.42K
+12.41%
Mr. Mark Bezjak
Mr. Mark Bezjak
President - Americas
President - Americas
13.13K
+8.09%
Ms. Lori Winkler
Ms. Lori Winkler
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
9.79K
-3.72%
收入明細
單位: USD更新時間: 4月6日 週日
單位: USD更新時間: 4月6日 週日
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
業務USD
名稱
營收
佔比
Knees
3.17B
41.33%
Hips
2.00B
26.03%
S E T
1.87B
24.30%
Other product category
640.30M
8.34%
地區USD
名稱
營收
佔比
United States
4.44B
57.81%
International
3.24B
42.19%
業務
地區
業務USD
名稱
營收
佔比
Knees
3.17B
41.33%
Hips
2.00B
26.03%
S E T
1.87B
24.30%
Other product category
640.30M
8.34%
股東統計
更新時間: 2月21日 週五
更新時間: 2月21日 週五
持股股東
股東類型
持股股東
股東統計
佔比
The Vanguard Group, Inc.
11.52%
Dodge & Cox
9.66%
T. Rowe Price Associates, Inc.
7.25%
BlackRock Institutional Trust Company, N.A.
5.53%
State Street Global Advisors (US)
4.54%
Other
61.48%
持股股東
股東統計
佔比
The Vanguard Group, Inc.
11.52%
Dodge & Cox
9.66%
T. Rowe Price Associates, Inc.
7.25%
BlackRock Institutional Trust Company, N.A.
5.53%
State Street Global Advisors (US)
4.54%
Other
61.48%
股東類型
股東統計
佔比
Investment Advisor/Hedge Fund
44.92%
Investment Advisor
39.00%
Hedge Fund
3.62%
Research Firm
1.91%
Pension Fund
1.87%
Bank and Trust
1.46%
Sovereign Wealth Fund
1.10%
Individual Investor
0.13%
Insurance Company
0.07%
Other
5.91%
機構持股
更新時間: 1月20日 週一
更新時間: 1月20日 週一
報告期間
機構數
持股數
持股佔比
持股變動
2025Q1
2008
186.69M
94.36%
-11.87M
2024Q4
2042
186.55M
93.71%
-18.21M
2024Q3
1986
185.93M
91.29%
-23.02M
2024Q2
1982
190.82M
92.76%
-16.12M
2024Q1
1974
190.22M
92.57%
-13.55M
2023Q4
1991
188.03M
89.99%
-18.28M
2023Q3
1984
188.24M
90.09%
-20.30M
2023Q2
2003
190.89M
91.52%
-16.92M
2023Q1
1993
190.05M
90.59%
-15.03M
2022Q4
1989
191.70M
91.35%
-15.71M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
The Vanguard Group, Inc.
22.80M
11.45%
-396.32K
-1.71%
Dec 31, 2024
Dodge & Cox
19.12M
9.6%
+2.04M
+11.98%
Dec 31, 2024
T. Rowe Price Associates, Inc.
14.35M
7.21%
+178.34K
+1.26%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
10.95M
5.5%
-351.66K
-3.11%
Dec 31, 2024
State Street Global Advisors (US)
8.98M
4.51%
-99.81K
-1.10%
Dec 31, 2024
American Century Investment Management, Inc.
5.92M
2.97%
-621.55K
-9.50%
Dec 31, 2024
Geode Capital Management, L.L.C.
4.88M
2.45%
-2.32K
-0.05%
Dec 31, 2024
PRIMECAP Management Company
4.80M
2.41%
-174.23K
-3.50%
Dec 31, 2024
Van Eck Associates Corporation
3.96M
1.99%
+218.69K
+5.85%
Dec 31, 2024
Franklin Mutual Advisers, LLC
2.81M
1.41%
+2.78M
+7.16K%
Dec 31, 2024
查看更多
持股ETF
更新時間: 4月6日 週日
更新時間: 4月6日 週日
機構名稱
佔比
American Century Focused Large Cap Value ETF
3.59%
Langar Global HealthTech ETF
3.52%
Leatherback Long/Short Alternative Yield ETF
3.37%
VanEck Morningstar Wide Moat Value ETF
3.25%
VanEck Morningstar Wide Moat ETF
2.65%
iShares U.S. Medical Devices ETF
2.48%
Amplify Cash Flow Dividend Leaders ETF
2.18%
Global X Aging Population ETF
1.9%
Cambria LargeCap Shareholder Yield ETF
1.9%
Invesco Bloomberg Pricing Power ETF
1.88%
查看更多
American Century Focused Large Cap Value ETF
佔比3.59%
Langar Global HealthTech ETF
佔比3.52%
Leatherback Long/Short Alternative Yield ETF
佔比3.37%
VanEck Morningstar Wide Moat Value ETF
佔比3.25%
VanEck Morningstar Wide Moat ETF
佔比2.65%
iShares U.S. Medical Devices ETF
佔比2.48%
Amplify Cash Flow Dividend Leaders ETF
佔比2.18%
Global X Aging Population ETF
佔比1.9%
Cambria LargeCap Shareholder Yield ETF
佔比1.9%
Invesco Bloomberg Pricing Power ETF
佔比1.88%
分紅派息
近5年累計派現 996.70M 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
Dec 18, 2024
ZBH.NB Final Cash Dividend of gross USD 0.24 paid on Jan 31, 2025 going ex on Dec 30, 2024
Dec 30, 2024
Jan 31, 2025
Dec 30, 2024
Aug 29, 2024
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Oct 31, 2024 going ex on Sep 30, 2024 with reinvestment option
Sep 30, 2024
Oct 31, 2024
Sep 30, 2024
May 13, 2024
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Jul 31, 2024 going ex on Jun 26, 2024 with reinvestment option
Jun 26, 2024
Jul 31, 2024
Jun 26, 2024
Feb 21, 2024
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Apr 30, 2024 going ex on Mar 27, 2024
Mar 29, 2024
Apr 30, 2024
Mar 27, 2024
Dec 14, 2023
ZBH.NB Final Cash Dividend of gross USD 0.24 paid on Jan 31, 2024 going ex on Dec 26, 2023
Dec 27, 2023
Jan 31, 2024
Dec 26, 2023
Aug 25, 2023
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Oct 31, 2023 going ex on Sep 28, 2023 with reinvestment option
Sep 29, 2023
Oct 31, 2023
Sep 28, 2023
May 15, 2023
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Jul 31, 2023 going ex on Jun 23, 2023 with reinvestment option
Jun 26, 2023
Jul 31, 2023
Jun 23, 2023
Mar 08, 2023
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Apr 28, 2023 going ex on Mar 28, 2023
Mar 29, 2023
Apr 28, 2023
Mar 28, 2023
Dec 15, 2022
ZBH.NB Final Cash Dividend of gross USD 0.24 paid on Jan 31, 2023 going ex on Dec 23, 2022
Dec 27, 2022
Jan 31, 2023
Dec 23, 2022
Aug 26, 2022
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Oct 31, 2022 going ex on Sep 29, 2022
Sep 30, 2022
Oct 31, 2022
Sep 29, 2022
查看更多
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
tradingkey.logo
tradingkey.logo
日內數據由路孚特(Refinitiv)提供,並受使用條款約束。歷史及當前收盤數據均由路孚特提供。所有報價均以當地交易所時間為準。美股報價的即時最後成交數據僅反映透過納斯達克報告的交易。日內數據延遲至少15分鐘或遵循交易所要求。
* 參考、分析和交易策略由提供商Trading Central提供,觀點基於分析師的獨立評估和判斷,未考慮投資者的投資目標和財務狀況。
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有